Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network.
Marine PerrierMathias BrugelLaura GérardBernard GoichotAstrid LièvreCome LepageVincent HautefeuilleChristine Do CaoDenis SmithPhilippe ThuillierJérôme CrosGuillaume CadiotThomas WalterLouis de MestierPublished in: European journal of endocrinology (2023)
Patients with glucagonoma had prolonged survival, even in the presence of metastases at diagnosis. Curative-intent surgery should always be considered. Chemotherapy, PRRT or liver-directed therapy seem to provide both substantial antitumor and antisecretory efficacy.